The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
CSL Behring (Australia) Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
216 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HIZENTRA human normal immunoglobulin 20% solution for subcutaneous injection 50 mL pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ANDEMBRY garadacimab 200 mg solution for injection in pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ANDEMBRY garadacimab 200 mg solution for injection in pre-filled syringe with needle safety device.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CSL US AlbuRx 5 human albumin 50 g/L (5% w/v) solution for intravenous infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CSL Hong Kong Albumex 5 NexGen Human Albumin 50 g/L Solution for Intravenous Infusion.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CSL United States of America Privigen normal immunoglobulin (human) (100g/L, 10%) solution for intravenous solution.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CSL New Zealand Fibrogammin Factor XIII, Freeze-Dried 1250 IU, powder forinjection vial with 20 mL diluent ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CSL Malaysia Intragam NexGen MY normal immunoglobulin (human) 5g 100 g/L, 10% solution for intravenous infusion.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CSL Malaysia Albumex 20 NexGen MY, Solution for infusion 20%.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CSL NZ Alburex 5 NZ human albumin 50 g/L (5% w/v) solution for intravenous infusion vial.